The healthcare expenditure on laboratory services in the Netherlands is predicted to remain stable at 0.07% of GDP from 2024 to 2027, reflecting a consistent allocation over these years. In 2028, a slight decrease to 0.06% of GDP is projected. As we are in 2024, this forecast indicates a minor decline expected at the end of the period.

When looking at the data in the context of year-on-year changes, the stability from 2024 to 2027 shows no variation, while the drop in 2028 signifies a decrease of approximately 14.29% compared to previous years’ data. The compound annual growth rate (CAGR) over the five years also aligns with this slight downward trend.

For future trends, pay attention to:

The effects of advancements in medical technology and potential cost reductions.
Changes in healthcare policies and funding that can impact expenditure patterns.
Potential increase in laboratory service demands due to demographic changes, such as aging population.